【問題】OECD 202 ?推薦回答

關於「OECD 202」標籤,搜尋引擎有相關的訊息討論:

OECD Test Guidelines for Chemicals。

... a new Guideline on Defined Approaches for Skin Sensitisation (OECD GL No. ... Stay tuned on Twitter: @OECD_ENV; For more information, please contact: ...。

[PDF] "Daphnia sp., Acute Immobilisation Test and Reproduction Test"。

Users of this Test Guideline should consult the Preface, in particular paragraphs 3, 4, 7 and 8. 202. Adopted: 4 April 1984. OECD GUIDELINE FOR TESTING OF ...: tw | tw。

OECD releases Transfer Pricing Guidance on Financial Transactions。

2020年2月11日 · The report is significant because it is the first time the OECD Transfer Pricing Guidelines include guidance on the transfer pricing aspects ...: 202? 。

OECD: Home page。

Working with over 100 countries, the OECD is a global policy forum that promotes policies to improve the economic and social well-being of people around the ...: 202? 。

OECD-FAO Agricultural Outlook 2021-2030。

2021年7月5日 · Over the ten-year Outlook period, agricultural markets are projected to remain weak, with growth in China weakening and biofuel policies ...: 202? 。

[PDF] Unclassified ENV/MC/CHEM(98)19/PART2 - OECD。

OECD TG 202 (part 2). 5. Prolonged toxicity study with fish: Fish. Early Life Stage Test. Oryzias, Jordanella, Zebrafish. Rainbow trout.。

[PDF] LINEAR ALKYLBENZENE SULFONATE (LAS) - OECD HPV。

Fairchild, J.F., Dwyer, F.J., LaPoint, T.W., Burch, S.A., and Ingersoll, ... A.M., Britton, L.N., Beall, C.E., McCormick, T.P., and Russel, G.L. 1997.。

[PDF] The in vivo erythrocyte Pig-a gene mutation assay – Part 1 - OECD。

2020年7月16日 · 7Toxicology Consulting Services, Bonita Springs, FL USA ... 202. Mutations transmitted though germ cells are of concern since they will.。

OECD Transfer Pricing Guidelines for Multinational Enterprises and ...。

2017年7月10日 · TABLE OF CONTENTS. Expand · Find out more about the OECD's work on transfer pricing · Sign-up to our e-mail alerts · Follow-us on Twitter @OECDtax.: 202? | 202?。

OECD Health Statistics 2021。

Data and research on health including biotechnology, cancer, health care, health spending, health insurance, fitness, dementia, disability, obesity, ...:


常見OECD 202問答


延伸文章資訊